Nishadil
Nishadil Ads Nishadil Astrology Nishadil Developers Nishadil Domains Nishadil Drive Nishadil Finance Nishadil Pay Nishadil Weather Nishdil Calendar Rewards
Signup Signin
Washington | 20°C (clear sky)
Topic Feed

IntelliaTherapeutics

Showing the latest stories and updates for this topic.
The Unseen Hurdles: Intellia's Gene-Editing Dream Hits a Safety Snag

The Unseen Hurdles: Intellia's Gene-Editing Dream Hits a Safety Snag
Intellia Shakes Up Expectations: A Deep Dive into Their Q1 Surprise

Intellia Shakes Up Expectations: A Deep Dive into Their Q1 Surprise
The CRISPR Crusade: Intellia's Ambitious Leap into the Heart of AML

The CRISPR Crusade: Intellia's Ambitious Leap into the Heart of AML
A Sudden Chill for Intellia: FDA Hits Pause on Groundbreaking Gene Therapy Trial

A Sudden Chill for Intellia: FDA Hits Pause on Groundbreaking Gene Therapy Trial
Intellia's Big Chill: Manufacturing Woes Trigger a Wave of Downgrades

Intellia's Big Chill: Manufacturing Woes Trigger a Wave of Downgrades
The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets

The Biotech Beat: Unpacking a Week of Breakthroughs, Billions, and Big Bets
The Daily Market Rhapsody: Unpacking Today's Big Swings and Startling Surprises

The Daily Market Rhapsody: Unpacking Today's Big Swings and Startling Surprises
The CRISPR Conundrum: A Pioneering Gene Therapy Paused by Unexpected Risk

The CRISPR Conundrum: A Pioneering Gene Therapy Paused by Unexpected Risk
A CRISPR Conundrum: Intellia's Trial Halt Jolts the Biotech World

A CRISPR Conundrum: Intellia's Trial Halt Jolts the Biotech World
The CRISPR Horizon: Intellia's Bold Leap Into Our Genetic Future, One Edit at a Time

The CRISPR Horizon: Intellia's Bold Leap Into Our Genetic Future, One Edit at a Time
Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry

Biotech's Pulse: Gene-Editing's Leap, Cancer's New Fights, and What's Stirring the Industry
The Shaking Ground: Intellia's Gene-Editing Dream Hits a Harsh Reality Check with Trial Setback

The Shaking Ground: Intellia's Gene-Editing Dream Hits a Harsh Reality Check with Trial Setback
Midday Market Movers: Biotech Rockets, Tech Soars, and a Coffee Giant Stumbles

Midday Market Movers: Biotech Rockets, Tech Soars, and a Coffee Giant Stumbles
Cathie Wood's ARK Invest Stacks Up on Alibaba, Baidu, and Biotech Gems in Active Week

Cathie Wood's ARK Invest Stacks Up on Alibaba, Baidu, and Biotech Gems in Active Week
Load more..